Pictet Asset Management (UK)’s Zymeworks ZYME Stock Holding History

Pictet Asset Management (UK)’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$36.8M	Buy	1,060,355 +297,383	+39%	+$9.43M	0.04%	407
2021 Q1	$24.1M	Sell	762,972 -134,137	-15%	-$5.45M	0.03%	466
2020 Q4	$42.4M	Buy	897,109 +185,146	+26%	+$8.6M	0.06%	333
2020 Q3	$33.2M	Buy	711,963 +137,441	+24%	+$4.72M	0.05%	339
2020 Q2	$20.7M	Buy	574,522 +242,182	+73%	+$8.92M	0.04%	394
2020 Q1	$11.8M	Sell	332,340 -16,005	-5%	-$655K	0.03%	446
2019 Q4	$15.8M	Sell	348,345 -129,339	-27%	-$4.7M	0.03%	485
2019 Q3	$11.8M	Buy	+477,684	New	+$12M	0.02%	498

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pictet Asset Management (UK)'s ZYME Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Zymeworks (ZYME) stake by 39% in Q2 2021, buying an estimated $9.43M and bringing the position to 1,060,355 shares worth $36.8M. The position accounts for 0.04% of the portfolio, ranked #407.

Pictet Asset Management (UK) first reported a position in ZYME in Q3 2019 and has held it in 8 quarters since. The position peaked at $42.4M in Q4 2020. 109 funds tracked by Wall St. Rank hold ZYME as of Q2 2021.

Pictet Asset Management (UK) held 1,060,355 shares of Zymeworks worth $36.8M as of Q2 2021.
Pictet Asset Management (UK) bought 297,383 Zymeworks shares in Q2 2021, an estimated $9.43M.
Zymeworks made up 0.04% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #407 holding.
Pictet Asset Management (UK) first reported a position in Zymeworks in Q3 2019 and has held it in 8 quarters since.
Pictet Asset Management (UK)'s Zymeworks position peaked at $42.4M in Q4 2020.
109 funds tracked by Wall St. Rank held Zymeworks as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.